
Merck and US-based biopharma firm NewLink Genetics’ investigational Ebola vaccine is being used in Phase III trials in West Africa. …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

